Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvage I-125 permanent brachytherapy after EBRT failure in prostate cancer
jRCT1051180150Completed
- Start
- Aug 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of goserelin in prostate cancer (PCa). Primary endpoints: Biochemical recurrence and Adverse events. Started Aug 2012; status: completed.
02
Drugs
goserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCT1051180150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051180150.